Author

Cory E. Bystrom

Ultragenyx Pharmaceutical (United States)ORCID 0000-0003-2015-6216Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Kevin Douglass· 1 shared Manju Gupta· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Kevin Douglass

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintMar 30, 2026

Development and fit for purpose validation of a quantitative LC-MS/MS method for heparan sulfate in cerebrospinal fluid as a biomarker for mucopolysaccharidosis type IIIA

Cory E. Bystrom, Kevin Douglass, Manju Gupta

The paper develops and validates a quantitative LC-MS/MS method for measuring heparan sulfate in CSF as a biomarker for MPS IIIA, showing high accuracy and reproducibility.

DOI 10.64898/2026.03.27.26348847

humanexperimental assay

𝕏 PostBluesky